1st Quarter - Report

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

Firm
Client
Income
—
Expenses
$2,450,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Chemicals/Chemical Industry CHM

Monitor legislative issues and administrative action related to the chemical industry.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —

Contacted: SENATE; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Monitor legislative and administrative action related to intellectual property protection.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
JULIE CORCORAN —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
BRIAN NAGLE —
URSULA WOJCIECHOWSKI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
CHRISTOPHER LEAHY —
LINDSAY A. MORRIS —
BRIAN NAGLE —
HALLIE UTLEY —

Contacted: Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); White House Office; SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Government Issues GOV

S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —
JAMES P MCVANEY —

Contacted: Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 1430 (115th), H.R. 469 (115th), H.R. 1431 (115th), S. 119 (115th)

Tariff (miscellaneous tariff bills) TAR

Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
JAMES P MCVANEY —
URSULA WOJCIECHOWSKI —

Contacted: U.S. Trade Representative (USTR); SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); White House Office; Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
JAMES P MCVANEY —
LINDSAY A. MORRIS —
URSULA WOJCIECHOWSKI —

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; White House Office; SENATE; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA)

Agriculture AGR

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017.

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; U.S. Trade Representative (USTR); SENATE

Bills named: S. 322 (115th), S. 629 (115th), H.R. 1029 (115th), H.R. 953 (115th), H.R. 909 (115th)

Taxation/Internal Revenue Code TAX

Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.

LobbyistCovered position, as disclosed
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
LINDSAY A. MORRIS —
HALLIE UTLEY —
URSULA WOJCIECHOWSKI —

Contacted: U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); White House Office; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1268 (115th), S. 108 (115th), H.R. 394 (115th), S. 85 (115th), H.R. 184 (115th)

Health Issues HCR

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
CHRISTOPHER LEAHY —
LINDSAY A. MORRIS —
BRIAN NAGLE —
HALLIE UTLEY —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Bills named: H.R. 749 (115th), S. 469 (115th), H.R. 2009 (115th), H.R. 1628 (115th), S. 404 (115th)

Budget/Appropriations BUD

Monitor legislative and administrative action on appropriations and budget. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; White House Office

Bills named: S.Con.Res. 3 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.